Expression of estrogen and progesterone receptors and Ki-67 antigen in Graves' disease and nodular goiter. 2013

Pawel Domoslawski, and Marzena Podhorska-Okolow, and Bartosz Pula, and Tadeusz Lukienczuk, and Piotr Dziegiel
Department of Histology and Embryology Medical University of Wroclaw.

Graves' Disease (GD) is an autoimmune disease with higher prevalence in women than in men. The aim of the study was to correlate the expression of estrogen (ER) and progesterone receptors (PR) as well as Ki- 67 cell proliferation index in thyroid sections of GD and nodular goiter (ND) patients. The study was performed on archival paraffin blocks of 77 GD and 25 ND patients using immunohistochemistry. Higher expression of progesterone receptors (p = 0.0276) and Ki-67 index (p < 0.0001) was observed in thyroids of GD as compared to NG patients. No correlations were found between the particular markers and patients' clinicopathological parameters, sex or age. A higher incidence of GD in women was not associated with different thyroid expression of ER and PR in comparison to men. No correlation was found between the expression of ER and PR and proliferation marker of thyrocytes of GD and ND patients. Significantly higher expression of the Ki-67 antigen in GD lesions was observed as compared to the NG.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D005260 Female Females
D006044 Goiter, Nodular An enlarged THYROID GLAND containing multiple nodules (THYROID NODULE), usually resulting from recurrent thyroid HYPERPLASIA and involution over many years to produce the irregular enlargement. Multinodular goiters may be nontoxic or may induce THYROTOXICOSIS. Nodular Goiter,Goiters, Nodular,Nodular Goiters
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Pawel Domoslawski, and Marzena Podhorska-Okolow, and Bartosz Pula, and Tadeusz Lukienczuk, and Piotr Dziegiel
January 2003, Menopause (New York, N.Y.),
Pawel Domoslawski, and Marzena Podhorska-Okolow, and Bartosz Pula, and Tadeusz Lukienczuk, and Piotr Dziegiel
July 2008, Ceska gynekologie,
Pawel Domoslawski, and Marzena Podhorska-Okolow, and Bartosz Pula, and Tadeusz Lukienczuk, and Piotr Dziegiel
June 2012, Pakistan journal of biological sciences : PJBS,
Pawel Domoslawski, and Marzena Podhorska-Okolow, and Bartosz Pula, and Tadeusz Lukienczuk, and Piotr Dziegiel
October 2005, Gynecologic oncology,
Pawel Domoslawski, and Marzena Podhorska-Okolow, and Bartosz Pula, and Tadeusz Lukienczuk, and Piotr Dziegiel
January 2002, Anticancer research,
Pawel Domoslawski, and Marzena Podhorska-Okolow, and Bartosz Pula, and Tadeusz Lukienczuk, and Piotr Dziegiel
January 2005, Gynecologic and obstetric investigation,
Pawel Domoslawski, and Marzena Podhorska-Okolow, and Bartosz Pula, and Tadeusz Lukienczuk, and Piotr Dziegiel
September 1991, Cancer,
Pawel Domoslawski, and Marzena Podhorska-Okolow, and Bartosz Pula, and Tadeusz Lukienczuk, and Piotr Dziegiel
September 2006, International seminars in surgical oncology : ISSO,
Pawel Domoslawski, and Marzena Podhorska-Okolow, and Bartosz Pula, and Tadeusz Lukienczuk, and Piotr Dziegiel
February 2008, The Journal of laryngology and otology,
Pawel Domoslawski, and Marzena Podhorska-Okolow, and Bartosz Pula, and Tadeusz Lukienczuk, and Piotr Dziegiel
January 1991, Endokrynologia Polska,
Copied contents to your clipboard!